The top legislator stressed the need to strengthen the system and capacity for the rule of law in foreign-related affairs, ...
BioArctic AB's (publ) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in San Diego December 1-4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback